Rybak SM - Search Results

1

Specifically targeting the CD22 receptor of human B-cell lymphomas with RNA damaging agents: a new generation of therapeutics.

Hursey M, Newton DL, Hansen HJ, Ruby D, Goldenberg DM, Rybak SM. Hursey M, et al. Among authors: rybak sm. Leuk Lymphoma. 2002 May;43(5):953-9. doi: 10.1080/10428190290021380. Leuk Lymphoma. 2002. PMID: 12148905 Review.

2

Targeting malignant B-cell lymphoma with a humanized anti-CD22 scFv-angiogenin immunoenzyme.

Krauss J, Arndt MA, Vu BK, Newton DL, Rybak SM. Krauss J, et al. Among authors: rybak sm. Br J Haematol. 2005 Mar;128(5):602-9. doi: 10.1111/j.1365-2141.2005.05356.x. Br J Haematol. 2005. PMID: 15725080 Free article.

3

Anti-CD22 Onconase: preparation and characterization.

Newton DL, Stockwin LH, Rybak SM. Newton DL, et al. Among authors: rybak sm. Methods Mol Biol. 2009;525:425-43, xiv. doi: 10.1007/978-1-59745-554-1_22. Methods Mol Biol. 2009. PMID: 19252847

4

Potent and specific antitumor effects of an anti-CD22-targeted cytotoxic ribonuclease: potential for the treatment of non-Hodgkin lymphoma.

Newton DL, Hansen HJ, Mikulski SM, Goldenberg DM, Rybak SM. Newton DL, et al. Among authors: rybak sm. Blood. 2001 Jan 15;97(2):528-35. doi: 10.1182/blood.v97.2.528. Blood. 2001. PMID: 11154233 Free article.

5

Specifically targeting the CD22 receptor of human B-cell lymphomas with RNA damaging agents.

Newton DL, Hansen HJ, Liu H, Ruby D, Iordanov MS, Magun BE, Goldenberg DM, Rybak SM. Newton DL, et al. Among authors: rybak sm. Crit Rev Oncol Hematol. 2001 Jul-Aug;39(1-2):79-86. doi: 10.1016/s1040-8428(01)00116-0. Crit Rev Oncol Hematol. 2001. PMID: 11418304 Review.

6

Preparation of recombinant RNase single-chain antibody fusion proteins.

Newton DL, Rybak SM. Newton DL, et al. Among authors: rybak sm. Mol Biotechnol. 2002 Jan;20(1):63-76. doi: 10.1385/MB:20:1:063. Mol Biotechnol. 2002. PMID: 11876300 Review.

7

Construction and characterization of RNase-based targeted therapeutics.

Newton DL, Futami J, Ruby D, Rybak SM. Newton DL, et al. Among authors: rybak sm. Methods Mol Biol. 2003;207:283-304. doi: 10.1385/1-59259-334-8:283. Methods Mol Biol. 2003. PMID: 12412481 No abstract available.

8

Efficient killing of CD22+ tumor cells by a humanized diabody-RNase fusion protein.

Krauss J, Arndt MA, Vu BK, Newton DL, Seeber S, Rybak SM. Krauss J, et al. Among authors: rybak sm. Biochem Biophys Res Commun. 2005 Jun 3;331(2):595-602. doi: 10.1016/j.bbrc.2005.03.215. Biochem Biophys Res Commun. 2005. PMID: 15850802

9

Unique recombinant human ribonuclease and inhibition of Kaposi's sarcoma cell growth.

Newton DL, Rybak SM. Newton DL, et al. Among authors: rybak sm. J Natl Cancer Inst. 1998 Dec 2;90(23):1787-91. doi: 10.1093/jnci/90.23.1787. J Natl Cancer Inst. 1998. PMID: 9839518

10

Natural and engineered cytotoxic ribonucleases: therapeutic potential.

Rybak SM, Newton DL. Rybak SM, et al. Exp Cell Res. 1999 Dec 15;253(2):325-35. doi: 10.1006/excr.1999.4718. Exp Cell Res. 1999. PMID: 10585255 Review. No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

83 results

Search Page

Filters